Prostatitis with Chlamydia Infection

dc.contributor.authorOripov Rustam Anvarovich
dc.date.accessioned2026-01-01T10:17:37Z
dc.date.issued2022-05-30
dc.description.abstractTreatment of urogenital chlamydia remains a difficult practical task. Due to the formation of resistance of these microorganisms to antibiotics, the duration of therapy increases, relapses often occur. At the same time, the increase in the frequency of this pathology currently tends to increase and is observed mainly among young and middle-aged people, which leads to a decrease in not only copulatory, but also reproductive function.In this regard, the choice of an effective drug in the treatment of prostatitis associated with chlamydia infection still remains an urgent problem
dc.formatapplication/pdf
dc.identifier.urihttps://zienjournals.com/index.php/tjms/article/view/1817
dc.identifier.uri10.62480/tjms.2022.vol8.pp126-128
dc.identifier.urihttps://asianeducationindex.com/handle/123456789/59358
dc.language.isoeng
dc.publisherZien Journals
dc.relationhttps://zienjournals.com/index.php/tjms/article/view/1817/1515
dc.rightshttps://creativecommons.org/licenses/by-nc/4.0
dc.sourceTexas Journal of Medical Science; Vol. 8 (2022): TJMS; 126-128
dc.source2770-2936
dc.subjectUrogenital prostatitis
dc.subjectchlamydia infection
dc.subjecteffectiveness of treatment
dc.subjectjosamycin
dc.titleProstatitis with Chlamydia Infection
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typePeer-reviewed Article

item.page.files

item.page.filesection.original.bundle

pagination.showing.labelpagination.showing.detail
loading.default
thumbnail.default.alt
item.page.filesection.name
anvarovich_2022_prostatitis_with_chlamydia_infection.pdf
item.page.filesection.size
205.64 KB
item.page.filesection.format
Adobe Portable Document Format

item.page.collections